GPX4 and cancer: The existence of cancer cell lines resistant to the GPX4 inhibitor RSL3 prompted Doll et al. [27] and Bersuker et al. [28] to explore alternative mechanisms to prevent ferroptosis, concurrently discovering that FSP1 protects human cells from ferroptosis [65].